Literature DB >> 34286444

CCL25 Signaling in the Tumor Microenvironment.

Hina Mir1,2, Shailesh Singh3,4,5.   

Abstract

Multiple checkpoint mechanisms are overridden by cancer cells in order to develop into a tumor. Neoplastic cells, while constantly changing during the course of cancer progression, also craft their surroundings to meet their growing needs. This crafting involves changing cell surface receptors, affecting response to extracellular signals and secretion of signals that affect the nearby cells and extracellular matrix architecture. This chapter briefly comprehends the non-cancer cells facilitating the cancer growth and elaborates on the notable role of the CCR9-CCL25 chemokine axis in shaping the tumor microenvironment (TME), directly and via immune cells. Association of increased CCR9 and CCL25 levels in various tumors has demonstrated the significance of this axis as a tool commonly used by cancer to flourish. It is involved in attracting immune cells in the tumor and determining their fate via various direct and indirect mechanisms and, leaning the TME toward immunosuppressive state. Besides, elevated CCR9-CCL25 signaling allows survival and rapid proliferation of cancer cells in an otherwise repressive environment. It modulates the intra- and extracellular protein matrix to instigate tumor dissemination and creates a supportive metastatic niche at the secondary sites. Lastly, this chapter abridges the latest research efforts and challenges in using the CCR9-CCL25 axis as a cancer-specific target.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Angiogenesis; CCL25; CCR9; Chemoresistance; Dendritic cells; Extracellular matrix; MMP; Macrophages; Metastasis; T cells; TGF-β; Tumor microenvironment; VEGF

Year:  2021        PMID: 34286444     DOI: 10.1007/978-3-030-62658-7_8

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  124 in total

Review 1.  Role of Toll-like receptors in inflammatory response in macrophages.

Authors:  A Aderem
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 2.  Perineural Invasion and Perineural Tumor Spread in Head and Neck Cancer.

Authors:  Richard L Bakst; Christine M Glastonbury; Upendra Parvathaneni; Nora Katabi; Kenneth S Hu; Sue S Yom
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-12-15       Impact factor: 7.038

3.  The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8(+) T cell immunity.

Authors:  Y-H Ahn; S-O Hong; J H Kim; K H Noh; K-H Song; Y-H Lee; J-H Jeon; D-W Kim; J H Seo; T W Kim
Journal:  Clin Exp Immunol       Date:  2015-05-17       Impact factor: 4.330

Review 4.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

Review 5.  Inflammation and cancer: back to Virchow?

Authors:  F Balkwill; A Mantovani
Journal:  Lancet       Date:  2001-02-17       Impact factor: 79.321

6.  Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.

Authors:  Caroline Aspord; Marie-Therese Leccia; Julie Charles; Joel Plumas
Journal:  Cancer Immunol Res       Date:  2013-09-26       Impact factor: 11.151

7.  Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.

Authors:  Farin F Amersi; Alicia M Terando; Yasufumi Goto; Richard A Scolyer; John F Thompson; Andy N Tran; Mark B Faries; Donald L Morton; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

Review 8.  Vascular endothelial growth factor and its relationship to inflammatory mediators.

Authors:  Laura S Angelo; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

9.  Cancer-associated fibroblasts lead tumor invasion through integrin-β3-dependent fibronectin assembly.

Authors:  Youmna Attieh; Andrew G Clark; Carina Grass; Sophie Richon; Marc Pocard; Pascale Mariani; Nadia Elkhatib; Timo Betz; Basile Gurchenkov; Danijela Matic Vignjevic
Journal:  J Cell Biol       Date:  2017-09-20       Impact factor: 10.539

10.  Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes.

Authors:  M L Albert; S F Pearce; L M Francisco; B Sauter; P Roy; R L Silverstein; N Bhardwaj
Journal:  J Exp Med       Date:  1998-10-05       Impact factor: 14.307

View more
  2 in total

1.  CCL25 Inhibition Alleviates Sepsis-Induced Acute Lung Injury and Inflammation.

Authors:  Demeng Xia; Sheng Wang; Anwei Liu; Lei Li; Panyu Zhou; Shuogui Xu
Journal:  Infect Drug Resist       Date:  2022-06-25       Impact factor: 4.177

Review 2.  NcRNAs: Multi‑angle participation in the regulation of glioma chemotherapy resistance (Review).

Authors:  Zhaomu Zeng; Yueyue Chen; Xiuchao Geng; Yuhao Zhang; Xichao Wen; Qingyu Yan; Tingting Wang; Chen Ling; Yan Xu; Junchao Duan; Kebin Zheng; Zhiwei Sun
Journal:  Int J Oncol       Date:  2022-05-04       Impact factor: 5.884

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.